跳至主要内容
临床试验/NCT05454059
NCT05454059已完成不适用

Investigation of Salivary Ceramide-1-Phosphate and Prostaglandin E2 Levels in Periodontitis Patients With Poorly and Well-Controlled Type 2 Diabetes and Effect of Non-Surgical Periodontal Treatment: A Randomized Controlled Clinical Trial

Ondokuz Mayıs University2 个研究点 分布在 2 个国家目标入组 102 人开始时间: 2020年10月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
2
主要终点
HbA1c levels

研究概览

简要总结

Diabetes and periodontal disease are the most common chronic multifactorial and inflammatory diseases in humans, and there is a bidirectional relationship between type 2 diabetes and periodontitis. With the negative effects of the control of these two diseases, it results in an increase in the severity of diabetes and periodontitis, and they affect many systems together. To elucidate the role of ceramide, which is one of the possible biochemical mechanisms between diabetes and the degree of glycemic control and periodontitis, in inflammation. Aim of this study is the measurement of C1P and PGE2 in saliva and the effect of non-surgical periodontal treatment, which includes the degree of control of diabetes, oral hygiene education, tooth surface cleaning and root surface arrangement, on 3 months.

A total of 102 subjects were included. Clinical periodontal measurements, saliva samples were collected from each individual at baseline and 3 months after non-surgical periodontal treatmet in periodontitis groups. Salivary C1P and PGE2 levels were determined by enzyme-linked immunosorbent assay (ELISA) method.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 30-65
  • Have not received periodontal treatment in the last 6 months,
  • Does not have any systemic disease and does not use drugs,
  • Not using local or systemic antibiotics in the last 3 months,
  • HbA1c <%7 for the controlled T2DM group,
  • HbA1c ≥7% for the uncontrolled T2DM group,
  • For female patients who are not in the pregnancy or lactation period,
  • Non-smoker,
  • Not regularly using mouthwash/mouthwash.

排除标准

  • Not being willing to participate in the study,
  • Under 30 years old, over 65 years old
  • Having any systemic disease affecting the periodontal condition,
  • To use any medication that may affect the inflammatory process in the last 3 months,
  • Using local or systemic antibiotics in the last 3 months,
  • To have had periodontal treatment in the last 6 months,
  • Being in pregnancy or lactation period for female patients,
  • Using mouthwash regularly

结局指标

主要结局

HbA1c levels

时间窗: baseline to 3 months after treatment

Blood test in routine biochemistry laboratory for evaluation of the change in HbA1c levels of patients with type 2 diabetes from baseline to 3 months after non-surgical periodontal treatment

PGE2 levels in saliva

时间窗: baseline to 3 months after treatment

Change in saliva PGE2 levels from baseline to 3 months after non-surgical periodontal treatment

C1P levels in saliva

时间窗: baseline to 3 months after treatment

Change in saliva C1P levels from baseline to 3 months after non-surgical periodontal treatment

次要结局

  • Bleeding on probing index (BOP)(baseline to 3 months after treatment)
  • Gingival index (GI)(baseline to 3 months after treatment)
  • Probing pocket depth(baseline to 3 months after treatment)
  • Clinical attachment level (CAL)(baseline to 3 months after treatment)
  • Plaque index (PI)(baseline to 3 months after treatment)

研究者

发起方
Ondokuz Mayıs University
申办方类型
Other
责任方
Principal Investigator
主要研究者

SELMAN YILMAZ CICEK

Principal Investigator

Ondokuz Mayıs University

研究点 (2)

Loading locations...

相似试验